BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32819261)

  • 1. Non-surgical Treatments for Lung Metastases in Patients with Soft Tissue Sarcoma: Stereotactic Body Radiation Therapy (SBRT) and Radiofrequency Ablation (RFA).
    Tetta C; Carpenzano M; Algargoush ATJ; Algargoosh M; Londero F; Maessen JG; Gelsomino S
    Curr Med Imaging; 2021; 17(2):261-275. PubMed ID: 32819261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
    Baumann BC; Bernstein KA; DeLaney TF; Simone CB; Kolker JD; Choy E; Levin WP; Weber KL; Muniappan A; Berman AT; Staddon A; Hartner L; Van Tine B; Hirbe A; Glatstein E; Hahn SM; Nagda SN; Chen YL
    J Surg Oncol; 2020 Oct; 122(5):877-883. PubMed ID: 32588468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.
    Jackson WC; Tao Y; Mendiratta-Lala M; Bazzi L; Wahl DR; Schipper MJ; Feng M; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):950-958. PubMed ID: 29485074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma.
    Feng XY; Li J; Li AM; Jing SH; Zhu XX; Wang Z
    World J Surg Oncol; 2022 Sep; 20(1):322. PubMed ID: 36171617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.
    Loi M; Duijm M; Baker S; Rossi L; Grunhagen D; Verhoef C; Nuyttens J
    Radiol Med; 2018 Nov; 123(11):871-878. PubMed ID: 29923086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.
    Jeong Y; Lee KJ; Lee SJ; Shin YM; Kim MJ; Lim YS; Lee HC; Jung J; Park JH; Kim JH; Kim SY; Yoon SM
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1962-1970. PubMed ID: 33594690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
    Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
    Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for sarcoma pulmonary metastases.
    Lebow ES; Lobaugh SM; Zhang Z; Dickson MA; Rosenbaum E; D'Angelo SP; Nacev BA; Shepherd AF; Shaverdian N; Wolden S; Wu AJ; Gelblum DY; Simone CB; Gomez DR; Alektiar K; Tap WD; Rimner A
    Radiother Oncol; 2023 Oct; 187():109824. PubMed ID: 37532104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma.
    Tetta C; Londero F; Micali LR; Parise G; Algargoush AT; Algargoosh M; Albisinni U; Maessen JG; Gelsomino S
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):303-315. PubMed ID: 32024603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
    Navarria P; Baldaccini D; Clerici E; Marini B; Cozzi L; Franceschini D; Bertuzzi AF; Quagliuolo V; Torri V; Colombo P; Franzese C; Bellu L; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):762-770. PubMed ID: 35987453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
    Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
    Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
    Dhakal S; Corbin KS; Milano MT; Philip A; Sahasrabudhe D; Jones C; Constine LS
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):940-5. PubMed ID: 21277105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
    Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
    Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Bi N; Shedden K; Zheng X; Kong FS
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.
    Ochiai S; Yamakado K; Kodama H; Nomoto Y; Ii N; Takaki H; Sakuma H
    Int J Clin Oncol; 2015 Jun; 20(3):499-507. PubMed ID: 25130494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases.
    Yu J; Kim DH; Lee J; Shin YM; Kim JH; Yoon SM; Jung J; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim SY; Kim JE; Park JH; Kim SY
    Cancer Res Treat; 2022 Jul; 54(3):850-859. PubMed ID: 34645129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.
    Lee J; Shin IS; Yoon WS; Koom WS; Rim CH
    Radiother Oncol; 2020 Apr; 145():63-70. PubMed ID: 31923711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
    Zhang R; Kang J; Ren S; Xing L; Xu Y
    Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.